Treg Depletion Licenses T Cell–Driven HEV Neogenesis and Promotes Tumor Destruction

Por Colbeck, Emily J., Jones, Emma, Hindley, James P., Smart, Kathryn, Schulz, Ralph, Browne, Molly, Cutting, Scott, Williams, Anwen, Parry, Lee, Godkin, Andrew, Ware, Carl F., Ager, Ann, Gallimore, Awen
Publicado no Cancer Immunol Res (2017)

Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors

Por Colbeck, Emily J., Hindley, James P., Smart, Kathryn, Jones, Emma, Bloom, Anja, Bridgeman, Hayley, McPherson, Rhoanne C., Turner, Darryl G., Ladell, Kristin, Price, David A., O'Connor, Richard A., Anderton, Stephen M., Godkin, Andrew J., Gallimore, Awen M.
Publicado no Oncotarget (2015)

IL-2(high) tissue-resident T cells in the human liver: Sentinels for hepatotropic infection

Por Pallett, Laura J., Davies, Jessica, Colbeck, Emily J., Robertson, Francis, Hansi, Navjyot, Easom, Nicholas J.W., Burton, Alice R., Stegmann, Kerstin A., Schurich, Anna, Swadling, Leo, Gill, Upkar S., Male, Victoria, Luong, TuVinh, Gander, Amir, Davidson, Brian R., Kennedy, Patrick T.F., Maini, Mala K.
Publicado no J Exp Med (2017)